The Global Prochlorperazine Maleate Market Size Was Valued at USD 120.4 Million in 2023 and is Projected to Reach USD 165.8 Million by 2032, Growing at a CAGR of 3.6% From 2024-2032. Prochlorperazine Maleate is a potent first-generation antipsychotic and antiemetic medication belonging to the phenothiazine class. It is primarily utilized in the medical field to manage severe nausea and vomiting...